| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Avantor, Inc. | Director | Common Stock | 36.3K | $828K | $22.83 | May 11, 2023 | Direct |
| Beam Therapeutics Inc. | Director | Stock Option (Right to Buy) | 23.1K | $564K | $24.40 | Jun 5, 2024 | Direct |
| Kyverna Therapeutics, Inc. | Director | Stock Option (right to buy) | 66.6K | Sep 16, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | Sep 16, 2024 | 1 | $0 | 4 | Sep 18, 2024 | Director |
| KYTX | Kyverna Therapeutics, Inc. | Sep 16, 2024 | 0 | $0 | 3 | Sep 18, 2024 | Director |
| BEAM | Beam Therapeutics Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| BEAM | Beam Therapeutics Inc. | Dec 13, 2023 | 1 | $0 | 4 | Dec 14, 2023 | Director |
| BEAM | Beam Therapeutics Inc. | Dec 13, 2023 | 0 | $0 | 3 | Dec 14, 2023 | Director |
| AVTR | Avantor, Inc. | May 11, 2023 | 1 | $0 | 4 | May 15, 2023 | Director |
| AVTR | Avantor, Inc. | May 12, 2022 | 1 | $0 | 4 | May 16, 2022 | Director |
| AVTR | Avantor, Inc. | Apr 1, 2022 | 1 | $0 | 4 | Apr 5, 2022 | Director |